The American Bar
Association (ABA) Section of Intellectual Property Law, Section of Science and
Technology, and Center for Professional Development will be offering a live
webinar and teleconference entitled "Single Claim Restriction Requirements:
The Interplay Between 35 USC
Section 112 and 35 USC Section 121" on February 5, 2013 from 12:00
- 1:30 pm (Eastern). Keisha Hylton-Rodic of Drinker Biddle & Reath LLP will
moderate a panel including Thomas L.
Irving of Finnegan, Henderson,
Farabow, Garrett & Dunner, LLP; Orlando Lopez of Burns
& Levinson LLP; Daniel M.
Sullivan of the U.S. Patent and
Trademark Office; and Robert D.
Titus of Eli Lilly. The panel will examine the balance between 35
U.S.C. § 112 and 35 U.S.C. § 121, and their interplay in the context of single
claim restriction requirements and restriction practice as it relates to Markush claims, as well as address
tactics that can be used during prosecution to avoid the pitfall of single
claim restrictions in chemical and biotech cases in contravention of current
case law on the practice.
The registration fee for
the webcast is $95 for members of any of the sections sponsoring the webinar,
$99 for government attorneys, $150 for ABA members, and $195 for the general
public. Those interested in registering
for the webinar, can do so here
or by calling 800-285-2221.
Comments